HPV, Chlamydia Trachomatis & Neisseria Gonorrhoeae PCR Panel, Qualitative in UAE | 650 AED | DHA Licensed

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via Real‑Time PCR with optional Whole Genome Sequencing – ISO 9001:2015 verified (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP mobile home collection by a trained healthcare professional (8 AM‑11 PM) with ISO‑certified cold‑chain transport.
Clinical Guidance: Complimentary telephonic post‑test interpretation session with a DHA‑licensed general practitioner.
Insurance & Payment: Direct billing verification via WhatsApp +971 54 548 8731 – 650 AED confirmed.

Test Overview & Methodology

HPV/Chlamydia/Gonorrhea Molecular Panel

This advanced PCR panel simultaneously detects Chlamydia trachomatis, Neisseria gonorrhoeae, and high‑risk HPV DNA with a single cervical swab, delivering comprehensive reproductive tract infection screening. Powered by qPCR and WGS backup, it identifies even low‑level pathogens, ensuring fully informed clinical decisions.

Feature	Our Test (qPCR/WGS)	Closest Alternative (Rapid Antigen)
Precision	99.9% diagnostic sensitivity, strain‑level typing via WGS	~85% sensitivity, no strain identification
Methodology	Real‑Time PCR (qPCR) + optional Whole Genome Sequencing	Immunochromatographic lateral flow (point‑of‑care)
Speed	Result in 10‑12 working days (cold‑chain optimized)	15–30 minutes, but may require PCR confirmation

Physician Insight & Safety Protocols

“In my practice, simultaneous molecular detection of these three pathogens empowers my patients with a clear understanding of their reproductive health. A negative panel provides reassurance, while a positive result allows early, targeted treatment that can prevent long‑term complications.”

“I always counsel my patients that no test replaces clinical correlation. Symptoms such as persistent pelvic pain, abnormal discharge, or postcoital bleeding should be discussed immediately, regardless of the laboratory outcome.”

“A qualitative PCR result is a powerful tool when interpreted within the full clinical picture. Should a serious infection be identified, I guide my patients through appropriate therapy and follow‑up testing.”

Medication Advisory

⚠️ Do not discontinue any prescribed treatment or start new supplements without consulting your attending physician. This does not replace clinical evaluation.

Safety Exclusion Criteria & Emergency Red Flags

Active heavy vaginal bleeding or menstruation on the day of scheduled swab – please postpone collection.
Known allergy to any component of the transport medium (rare).
Seek emergency care immediately if you experience: sudden severe pelvic/abdominal pain, fever >38.5 °C with chills, fainting, or purulent discharge with systemic illness.
Home collection is not suitable for patients who are hemodynamically unstable.

Patient FAQ & Clinical Guidance

1. What does the HPV, Chlamydia & Gonorrhea PCR qualitative panel detect?

Snippet: This molecular panel detects the DNA of Chlamydia trachomatis, Neisseria gonorrhoeae, and high‑risk HPV types from a single cervical swab with near‑perfect sensitivity, confirming active infection.

Unlike culture or rapid tests, qPCR amplifies pathogen genetic material even at extremely low concentrations, ruling out false‑negative results when symptoms are present.

2. How should I prepare for the cervical swab collection?

Snippet: No fasting or special preparation is required; simply avoid douching, vaginal creams, or intercourse for 24 hours before the sample is taken.

Our ISO‑certified healthcare professional will use a sterile, single‑use swab and place it immediately into the refrigerated transport container to preserve nucleic acid integrity.

3. When will I receive my report, and how is it interpreted?

Snippet: Your qualitative report will be ready in 10‑12 working days and clearly states “Detected” or “Not Detected” for each pathogen, including any high‑risk HPV subtype identified by WGS.

A separate tele‑consultation with Dr. Ajay Singh’s team is offered at no extra cost to explain the implications, recommend confirmatory testing if needed, and coordinate treatment with your primary gynecologist.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE operates under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing, patient consent, and safety protocols comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. Your data is encrypted, processed within UAE jurisdiction, and never shared without explicit consent.

Clinical & Logistical Metadata

Test Name	HPV, Chlamydia Trachomatis & Neisseria Gonorrhoeae PCR Panel, Qualitative
Price (AED)	650 AED
Turnaround Time	10–12 working days
Sample Type / Matrix	Cervical swab (endocervical)
Methodology Used	Real‑Time PCR (qPCR) with optional Whole Genome Sequencing
ICD-10-CM Code	B97.7 (HPV), A56.0 (Chlamydia), A54.0 (Gonorrhea)
LOINC Code	71431-1
DHA Facility License & Laboratory Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE